Loading clinical trials...
Loading clinical trials...
A Phase II Study of High Dose Radiotherapy in Combination With Pembrolizumab Plus Chemotherapy in Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Conditions
Interventions
Radiation Therapy
Pembrolizumab
+9 more
Locations
1
United States
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States
Start Date
October 22, 2025
Primary Completion Date
February 12, 2027
Completion Date
February 13, 2028
Last Updated
April 17, 2026
NCT06500455
NCT05673200
NCT04550494
NCT04704661
NCT05372640
NCT07112053
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions